Results 151 to 159 of about 27,127 (159)
Some of the next articles are maybe not open access.
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis.
JAMA OncologyImportance Kidney light chain (AL) amyloidosis is associated with a risk of progression to kidney replacement therapy (KRT) and death. Several studies have shown that a greater reduction in proteinuria following successful anticlonal therapy is ...
Eli Muchtar +30 more
semanticscholar +1 more source
Acta Haematologica, 2020
Immunoglobulin light-chain amyloidosis (AL) is a disease with limited treatment options due to the frailty of patients caused by organ damage. Since the clonal plasma cells often contain the cytogenetic aberration t(11;14), the Bcl-2 inhibitor venetoclax
Charlotte Gran +3 more
semanticscholar +1 more source
Immunoglobulin light-chain amyloidosis (AL) is a disease with limited treatment options due to the frailty of patients caused by organ damage. Since the clonal plasma cells often contain the cytogenetic aberration t(11;14), the Bcl-2 inhibitor venetoclax
Charlotte Gran +3 more
semanticscholar +1 more source
Expert Review of Hematology, 2020
Introduction Immunoglobulin light chain (AL) amyloidosis is one of the most frequent systemic amyloidosis in Western countries. It is caused by a B-cell clone producing a misfolded light chain (LC) that deposits in organs.
M. Basset +3 more
semanticscholar +1 more source
Introduction Immunoglobulin light chain (AL) amyloidosis is one of the most frequent systemic amyloidosis in Western countries. It is caused by a B-cell clone producing a misfolded light chain (LC) that deposits in organs.
M. Basset +3 more
semanticscholar +1 more source
Amyloid: Journal of Protein Folding Disorders, 2020
Background: The aim of the present prospective study (ClinicalTrials.gov Identifier: NCT02111538) was to assess the prognostic value of phase angle (PhA), derived from bioimpedance vectorial analysis (BIVA), in patients affected by systemic amyloid light-
R. Caccialanza +16 more
semanticscholar +1 more source
Background: The aim of the present prospective study (ClinicalTrials.gov Identifier: NCT02111538) was to assess the prognostic value of phase angle (PhA), derived from bioimpedance vectorial analysis (BIVA), in patients affected by systemic amyloid light-
R. Caccialanza +16 more
semanticscholar +1 more source
Systemic immunoglobulin light chain amyloidosis
Nature Reviews Disease Primers, 2018G. Merlini +6 more
semanticscholar +1 more source
Immunoglobulin Light Chain Amyloidosis.
Mayo Clinic proceedingsMahin Bhatt +2 more
semanticscholar +1 more source

